David Collard, DPM
Primary Podiatric Medicine · Mount Airy, NCNPI 1659783967
Payments from drug & device makers
What this record shows
10 manufacturers reported payments, led by Biopro, Inc. at 57.5% of the total. Reporting peaked in 2020 at $750 and has fallen 82.8% since, to $129 in 2025. That places this record below the midpoint for primary podiatric medicine clinicians in NC, where the typical reported total is $1,305.
Across 14 payments — averaging $93.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biopro, Inc.$750
- Organogenesis Inc.$163
- Convatec Inc.$140
- Fusion Orthopedics USA, LLC$108
- Triad Life Sciences Inc.$55
- Boston Scientific$29
- plus $60 from 4 others
What the payments were for
- Consulting fees$75057%
- Food & beverage$55543%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biopro, Inc. | 1 | $750 |
| Organogenesis Inc. | 3 | $163 |
| Convatec Inc. | 3 | $140 |
| Fusion Orthopedics USA, LLC | 1 | $108 |
| Triad Life Sciences Inc. | 1 | $55 |
| Boston Scientific | 1 | $29 |
| Medartis Inc. | 1 | $17 |
| Nevro Corp. | 1 | $15 |
| Aroa Biosurgery Incorporated | 1 | $15 |
| Abbott | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AQUACEL AG$119
How this compares
$1,305 in reported general payments places this provider in the 50th percentile of 64 primary podiatric medicine providers in North Carolina.
See all primary podiatric medicine providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 47 | $1,284 |
| Ammonium Lactate | 18 | $402 |
| Colchicine | 29 | $283 |
| Triamcinolone Acetonide | 14 | $126 |
| Cephalexin | 25 | $105 |
| Clindamycin Hcl | 11 | $101 |
| Gabapentin | 12 | $59 |
| Ciprofloxacin Hcl | 12 | $34 |
| Meloxicam | 13 | $18 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Mount Airy
- Daniel WilkesMount Airy$3K
- Jeffrey HunterMount Airy$696
- Robin FranceMount Airy$90
- Ashma DavidsonStatesville$32K
- Joseph KiblerSupply$23K
- Jacob PaniciCary$13K
- Ythan WebsterNew Bern$10K
- Jon StancilGreenville$9K
- Kevin McDonaldConcord$8K
- Eric WardMatthews$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.